# An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants

> **NCT03634969** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 50 (actual)

## Conditions studied

- Cardiac Failure
- Myocardial Failure

## Interventions

- **DRUG:** BMS-986224

## Key facts

- **NCT ID:** NCT03634969
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-14
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634969, "An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03634969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*